Latest IBD Stories
NEW YORK, Dec.
PTG-100, a Novel Peptide as an 'Oral Targeted Therapy' for Inflammatory Bowel Diseases MILPITAS, Calif., Dec.
CCFA highlights the now 1.6 million Americans with these autoimmune diseases with new social media campaign during Crohn's & Colitis Awareness Week December 1-7, 2014 NEW YORK, Dec.
PINEHURST, N.C., Oct.
"Get Your Full Course" addresses diet and nutritional considerations related to inflammatory bowel diseases and highlights Sunny's personal story of living with ulcerative colitis HORSHAM,
AG014 Safe and Well Tolerated, Successful Localized GI Delivery of Drug With No Systemic Exposure GHENT, Belgium, Oct.
Regarded as one of the world's leading experts in the field of pediatric inflammatory bowel disease (IBD), Marla Dubinsky, MD, has been appointed Chief of Pediatric Gastroenterology in the
The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW
Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug.